Hanlin Gao - Apr 30, 2025 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Chief Scientific Officer
Signature: /s/ Paul Kim as Attorney-in-Fact
Stock symbol: FLGT
Transactions as of: Apr 30, 2025
Transactions value $: -$1,371
Form type: 4
Date filed: 5/2/2025, 04:53 PM
Previous filing: Apr 29, 2025
Next filing: May 28, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gao Hanlin	Chief Scientific Officer	C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE	/s/ Paul Kim as Attorney-in-Fact	2025-05-02	0001684532

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Tax liability	-$1.37K	-79	-0.01%	$17.35	963K	Apr 30, 2025	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021.